NovaBay Pharmaceuticals, Inc. (NBY)

Last Closing Price: 1.39 (2026-03-06)

Earnings Announcements: Estimated vs Actual

On 2025-11-07, NovaBay Pharmaceuticals, Inc. (NBY) announced earnings per share of $-1.15 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $-1.05.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2025-11-07 2025-09-30 $-1.05 $-1.15
2025-08-14 2025-06-30 $-1.05 $-1.70
2025-05-15 2025-03-31 $-1.20 $-3.05
2024-11-07 2024-09-30 $-1.40 $-3.00
2024-08-13 2024-06-30 -- $-6.85
2024-05-09 2024-03-31 -- $-24.48
2024-03-26 2023-12-31 -- $-166.08
2023-11-09 2023-09-30 -- $-64.69
2023-08-10 2023-06-30 -- $-222.03
2023-05-11 2023-03-31 -- $-148.60
2023-03-30 2022-12-31 -- $-756.99
2022-11-14 2022-09-30 -- $-611.28
2022-08-11 2022-06-30 -- $-244.51
2022-05-12 2022-03-31 -- $0.00
2022-03-29 2021-12-31 -- $-122.26
2021-11-11 2021-09-30 -- $-305.64
2021-08-12 2021-06-30 -- $-244.51
2021-05-06 2021-03-31 -- $-244.51
2021-03-25 2020-12-31 -- $-244.51
2020-11-12 2020-09-30 -- $-489.02
2020-08-06 2020-06-30 -- $-916.92
2020-05-07 2020-03-31 -- $-366.77
2020-03-26 2019-12-31 -- $-794.66
2019-11-07 2019-09-30 -- $-122.26
2019-08-07 2019-06-30 -- $-855.79
2019-05-09 2019-03-31 -- $-1467.06
2019-03-28 2018-12-31 $-855.79 $-550.15
2018-11-14 2018-09-30 $-550.15 $-672.40
2018-08-07 2018-06-30 $-733.53 $-916.92
2018-05-10 2018-03-31 $-427.89 $-855.79
2018-03-20 2017-12-31 $-305.64 $122.26
2017-11-14 2017-09-30 $-550.15 $-978.04
2017-08-10 2017-06-30 $-733.53 $-672.40
2017-05-11 2017-03-31 $-855.79 $-1589.32
2017-03-23 2016-12-31 $-733.53 $-794.66
2016-11-10 2016-09-30 -- $-2078.34
2016-08-11 2016-06-30 -- $-2200.60
2016-05-12 2016-03-31 -- $-7029.68
2016-03-03 2015-12-31 -- $-7702.09
2015-11-17 2015-09-30 -- $-10697.34
2015-08-13 2015-06-30 -- $-10697.34
2015-05-14 2015-03-31 -- $-13753.73
2015-03-26 2014-12-31 -- $-13753.73